In this talk we discuss the issue of conducting trials in very rare diseases. The need for treatment is great, but the scientific rigor must remain high. The talk discusses ways to borrow information from existing historical trials in order to enhance future trials. In the setting of very rare diseases this approach can preserve the scientific rigor while greatly decreasing the sample size.